In simplest terms, APS is an autoimmune disorder in which the body doesn't
recognize
parts of its own cells and creates antibodies to attack them. When a woman
with undiagnosed, untreated APS gets pregnant, her body may
begin to reject the fetus.

Four years ago, I miscarried at 12 weeks. I sat in my OB's office
insisting this loss wasn't nature's way of handling an unviable arrangement
of chromosomes. Citing my nagging intuition, I asked to be tested for
autoimmune disorders, which I'd read could cause miscarriage. My OB kindly
and patiently convinced me doing the necessary blood work would waste time
and money. She saw no evidence to indicate that my miscarriage was anything
out
of the ordinary.
But the evidence showed up in spades when I got pregnant again
several
months later; my routine syphilis test came back positive. A more
sophisticated blood panel confirmed the obvious: I did not have a venereal
disease. What I did have, however, were unusually high levels of
antinuclear
antibodies, which can cause a false positive syphilis result. After I
underwent more lab work, I learned I had Antiphospholipid Antibody Syndrome
(APS), an obscure, enigmatic autoimmune condition that more often affects
women, many of whom don't even know they have it until their pregnancies go
awry. Only 8 weeks along, I was classified as a high-risk obstetric
patient and began anticoagulant therapy to keep from miscarrying again.
What is Antiphospholipid Antibody Syndrome?
So what is this little-known culprit with a fancy name? In simplest
terms, APS is an autoimmune disorder in which the body doesn't recognize
parts of its own cells and creates antibodies to attack them. According to
Dr. Victoria A. Seligman, a rheumatology fellow at the University of
California, San Francisco, APS is diagnosed when a patient has one or more
of
the following criteria:
- Positive antibodies test (includes lupus anticoagulant antibody,
anticardiolipin antibody, and false positive syphilis screen) on two
separate occasions, at least 8 weeks apart;
- Recurrent fetal loss
- Low platelet count
- Clotting events
Seligman stresses that not every woman who tests positive for the
antibodies has APS. An estimated 2 to 5 percent of women have elevated
antibody
levels, but only 10 to 20 percent of this group have problems in pregnancy.
For those
in the high-risk category, possible pregnancy risks include:
- Miscarriage
- Clotting events, also postpartum
- Prematurity and intrauterine growth retardation (IUGR)
- Pre-eclampsia
Anticoagulant Therapy During Pregnancy
When a woman with undiagnosed, untreated APS gets pregnant, her body may
begin to reject the fetus. Antibodies form tiny blood clots that enter the
placenta and shut off the supply of oxygen and nutrients to the baby,
resulting in miscarriage. Although doctors used to wait to diagnose APS
until a woman had three consecutive pregnancy losses, many OBs now try to
prevent this needless suffering by testing a patient after one or two
losses.
Roberta Montgomery of Los Angeles had a normal pregnancy with her
son,
Roland, now 2 years old. But her second pregnancy ended at 11 weeks after a
previous ultrasound had shown a healthy fetal heartbeat. Thinking this an
unusual development, Roberta's astute OB checked her for APS and found she
had moderate levels of antiphospholipid antibodies. Because Roberta wanted
to get pregnant again, her OB sent her to Dr. Hal Danzer, a Beverly Hills
fertility specialist. Dr. Danzer prescribed two blood thinners -- baby
aspirin
and heparin -- to prevent clots. Both medications are considered safe
during
pregnancy and heparin has proven extremely beneficial in combating
miscarriage and intrauterine growth retardation.
Under Danzer's supervision, Roberta learned to give herself heparin shots
in
the stomach twice a day while she was trying to conceive to facilitate
implantation. When she got pregnant -- fortunately, after just a couple of
months -- she maintained the heparin therapy until the end of her second
trimester. Her placenta and amniotic fluid were in good condition and the
fetus was growing normally -- all signs that the heparin was indeed keeping
clots from forming. With Danzer's permission, Roberta stopped the heparin
shots at the beginning of her third trimester and continued taking a daily
baby aspirin for the duration of her pregnancy. Although he arrived 2
weeks early, Roberta's second son Bobby, now 5 months, weighed in at a
strapping 8 pounds, 11 ounces.
Not every woman with APS needs to take heparin during pregnancy.
After
miscarrying at 16 weeks, Kathy Hennessy of Greenville, South Carolina
learned
she had low levels of antiphospholipid antibodies. Because her condition
was
borderline, she required only baby aspirin during her second pregnancy.
Daughter Emma Gwynne, now 17 months, was born safely one week late
weighing 9
pounds, 7 ounces.
Read part two here.